Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of November 10, 2026, XLO trades at $8.98 with a market cap of $56.72M and a P/E ratio of -1.89. XLO moved -0.22% today. Year to date, XLO is -4.51%; over the trailing twelve months it is -20.52%. Its 52-week range spans $6.47 to $16.52. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for XLO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $8.98 |
| Market Cap | $56.72M |
| P/E Ratio | -1.89 |
| EPS | $-4.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.52 |
| 52-Week Low | $6.47 |
| Volume | 451 |
| Avg Volume | 0 |
| Revenue (TTM) | $64.09M |
| Net Income | $-21.83M |
| Gross Margin | 0.00% |
XLO analyst coverage data. Average price target: $0.00.